Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-08
2005-02-08
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S349000, C514S300000, C546S122000
Reexamination Certificate
active
06852721
ABSTRACT:
The present invention relates to diazabicyclic compounds, preferably to N-aryl diazabicyclic compounds. Of particular interest are 2-pyridinyl diazabicyclic compounds, such as (1S,4S)-2-(5-(3-methoxyphenoxy)-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane. Other exemplary compounds of the present invention include (1S,4S)-2-(5-(4-methoxyphenoxy)-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane, (1S,4S)-2-(5-(3-thienyl)-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane, (1S,4S)-2-(5-(4-fluorophenoxy)-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane, and (1S,4S)-2-(5-benzoyl-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane. The present invention also relates to prodrug derivatives of the compounds of the present invention.
REFERENCES:
patent: 5478939 (1995-12-01), Trybulski et al.
patent: 5510355 (1996-04-01), Bencherif et al.
patent: 5817679 (1998-10-01), Shen et al.
patent: 5852041 (1998-12-01), Cosford et al.
patent: 5853696 (1998-12-01), Elmaleh et al.
patent: 5922723 (1999-07-01), Bencherif et al.
patent: 5952339 (1999-09-01), Bencherif et al.
patent: 5969144 (1999-10-01), London et al.
patent: 6022868 (2000-02-01), Olesen et al.
patent: 6060473 (2000-05-01), Shen et al.
patent: 6635645 (2003-10-01), Lochead et al.
patent: 7-61940 (1995-03-01), None
patent: WO 9630372 (1996-10-01), None
patent: WO 9711072 (1997-03-01), None
patent: WO 9713770 (1997-04-01), None
patent: WO9740049 (1997-10-01), None
patent: WO 9854182 (1998-12-01), None
patent: WO 0044755 (2000-08-01), None
patent: WO0044755 (2000-08-01), None
patent: 00 44755 (2000-08-01), None
patent: WO 0058311 (2000-10-01), None
patent: 00 66586 (2000-11-01), None
patent: WO0066586 (2000-11-01), None
International Search Report for PCT/US01/16941.
Viltemagna et al., “Nicotine and Related Compounds as PET and SPECT Ligunds,” Neurocal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities, 1998, pp. 235-250.
Barlocco et al., “Mono-and Disubsituted-3-8-diazabicycle [3.2.1]octane Derivatives as Analgesics Structurally Related to Epitaidine: Synthesis, Activity, and Modeling,” J. Med Chem, vol. 41, 1998, pp. 674-681.
Cheng et al., “Synthesis and binding of 6,7,8,9-tetrahydro-5H-pyrido[3,4-α]azepine and related ring-opened analogs at central nicotine receptors,” Eur. J. Med. Chem, vol. 34, 1999, pp. 177-190.
Williams et al. “Neuronal Nicotinic Acetylcholine Receptors,” DN&P, vol. 7, No. 4, May 1994, pp. 205-223.
Badio et al., “Synthesis and nicotinic activity of aplboxidine: an isoxazole analogue of epibatidine,” European Journal of Pharmacology, vol. 321, No. 2, 1997, pp. 180-194.
Olive et al., “Synthesis of New Open-Ring and homo-Epibatidine Analogues from Tropinone,” J. Org. Chem, 3 pages.
Clark Thomas Jeffrey
Dull Gary Maurice
Lynm Dwo
Miao Lan
Miller Craig Harrison
Liu Hong
Raymond Richard L.
Targacept, Inc.
Womble Carlyle Sandridge & Rice PLLC
LandOfFree
Pharmaceutical compositions and methods for use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and methods for use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods for use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3463633